Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Researchers Obtain Key Insights into How the Internal Body Clock is Tuned
Friday, August 22, 2014
New way to regulate internal body clocks by long non-coding RNA.

Novel Gene Predicts Both Breast Cancer Relapse and Response to Chemotherapy
Thursday, August 21, 2014
A predictive marker discovered by scientists at A*STAR and NUS could help doctors classify breast cancer patients for more effective treatment.

Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement
Thursday, August 21, 2014
Phase I study to evaluate OPDIVO (nivolumab), Bristol-Myers Squibb’s investigational PD-1 immune checkpoint inhibitor, with Celgene’s ABRAXANE® for multiple cancers.

Illumina Announces Oncology CDx Partnership with AstraZeneca, Janssen and Sanofi
Thursday, August 21, 2014
Illumina, forms collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing (NGS)-based oncology test system.

NIH Launches 3 Integrated Precision Medicine Trials
Wednesday, August 20, 2014
Findings to answer questions about addition of targeted therapies in earlier stage disease and help understand the prevalence and natural history of these genomic changes in earlier stage lung cancer.

Computer Model Reveals Cancer's Energy Source
Tuesday, August 19, 2014
Findings focused on the energy-making process in cancer cells known as the Warburg Effect.

Immune Cells get Cancer-Fighting Boost From Nanomaterials
Monday, August 18, 2014
Yale researchers used bundled carbon nanotubes to incubate cytotoxic T cells.

FDA Approves Roche’s Advanced Cervical Cancer Chemotherapy
Monday, August 18, 2014
Avastin is the first biologic medicine approved in combination with chemotherapy to help women with this type of cancer live longer than with chemotherapy alone.

New Ways to Treat Solid Tumours
Friday, August 15, 2014
An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3078
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv